
Nutritional Outlook interviews CRN's Judy Blatman on just where multivitamins stand these days.

Nutritional Outlook interviews CRN's Judy Blatman on just where multivitamins stand these days.

In response to the Bayer Phillips’ Colon Health case, the dietary supplement industry says the agency’s substantiation bar is too high.

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

Searching for trends in recent FTC consent orders and related motions

The bill would enhance DEA's ability to enforce against supplement spikers by expanding the list of controlled substances.

Vendors should be held to certain legal requirements-for instance, that farmers selling produce actually grow the produce themselves.

Why it may pay for supplement firms not to settle with patent trolls

But questionable antiaging and diabetes claims are also on the rise.

Chr. Hansen says the process was more complicated because this was the first time the company had filed for a vaginal health claim.

The claim is for Chr. Hansen’s RC-14 and GR-1 Probio-Tech bacterial strains, which target women’s vaginal health.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

Here are five of the biggest struggles companies are likely to encounter under FDA's new nutrition label proposal.

China should adopt a structure-function claims system similar to what exists in the United States, USCHPA says.

Beginning in December, EU manufacturers must call out allergens such as celery on ingredient lists.

Two industry leaders offer advice to the next head of FDA’s Division of Dietary Supplements-whoever she or he may be.

Up to 5% of products are currently in danger of non-compliance, says FDA.

David Kessler, MD, says there's no reason for ingredient labels to be confined to the sides and backs of products.

Choosing the right testing techniques while still keeping an eye on the bottom line.

Businesses may need to alter their practices to stay within the new lines set by the WHO and FAO's Codex Alimentarius Commission.

Missouri children with epileptic seizures can now use hemp CBD extracts when other treatments don't work.